Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome

GSK Investigational Site, Brussels

GSK Investigational Site, St Leonards

GSK Investigational Site, Leuven

GSK Investigational Site, West Perth

GSK Investigational Site, Bethesda

GSK Investigational Site, Richmond

GSK Investigational Site, Bad Bramstedt

GSK Investigational Site, Hanover

GSK Investigational Site, Bologna

GSK Investigational Site, Cincinnati

GSK Investigational Site, Madison

GSK Investigational Site, Rochester

GSK Investigational Site, Lille

GSK Investigational Site, Denver

GSK Investigational Site, Munich

GSK Investigational Site, Salt Lake City

GSK Investigational Site, San Diego

GSK Investigational Site, Suresnes

GSK Investigational Site, Boston

GSK Investigational Site, Nashville

GSK Investigational Site, Winnipeg

GSK Investigational Site, Halifax

GSK Investigational Site, Hamilton

GSK Investigational Site, Toronto